# Clopidogrel Pharmacogenomics Project

> **NCT01097343** · PHASE2 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 50 (actual)

## Conditions studied

- Disease Susceptibility

## Interventions

- **DRUG:** clopidogrel 75 mg
- **DRUG:** Clopidogrel 150 mg

## Key facts

- **NCT ID:** NCT01097343
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-04
- **Final completion:** 2011-05
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01097343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01097343, "Clopidogrel Pharmacogenomics Project". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01097343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*